Literature DB >> 22270141

Evaluation of the anti-peristaltic effect of glucagon and hyoscine on the small bowel: comparison of intravenous and intramuscular drug administration.

Andreas Gutzeit1, Christoph A Binkert, Dow-Mu Koh, Klaus Hergan, Constantin von Weymarn, Nicole Graf, Michael A Patak, Justus E Roos, Marcus Horstmann, Sebastian Kos, Simone Hungerbühler, Johannes M Froehlich.   

Abstract

PURPOSE: To evaluate prospectively duration and effectiveness of aperistalsis achieved by glucagon(GLU) or hyoscine N-butylbromide(HBB) following various administration routes.
MATERIALS AND METHODS: Six volunteers underwent Magnetic Resonance Imaging (MRI) after standardized oral preparation in random order five separate MR examinations with both spasmolytic agents (HBB intravenous(i.v.) or intramuscular(i.m.), GLU i.v. or i.m., and a combined scheme). The MR protocol included a sagittal 2D cross-section of the small bowel with a temporal resolution of 0.55 s acquired over 60 to 90 min. To quantify bowel motility, small bowel cross-sectional areas were summated over time.
RESULTS: The anti-peristaltic i.v. effects of HBB and glucagon started on average after 85 s/65 s and ended after 21 min/23.3 min, respectively. By comparison, the anti-peristaltic effects of i.m. HBB and glucagon started significantly later 5.1/11.6 min (P = 0.001; Wilcoxon signed ranks test) and lasted for 17.7/28.2 min with greater inter-individual differences (P = 0.012; Brown-Forsythe test). The combined scheme resulted in a rapid onset after 65 s with effect duration of 31 min.
CONCLUSION: Anti-peristaltic effects on the small bowel are drug dependant, i.e., their onset is faster and more reliable when administering i.v. than i.m.. Combining i.v. GLU with i.m. HBB provides an early onset of effect, sustained spasmolysis and the highest degree of motility impairment. KEY POINTS: • Anti-persitaltic agents are widely used before various diagnostic procedures of the abdomen. • The combination of iv-glucagon with im-hyoscine provides reliable spasmolysis with early onset. • Intravenous spasmolysis is more reliable compared to intramuscular administration. • Intravenous glucagon has a prolonged spasmolytic effect compared to intravenous hyoscine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22270141     DOI: 10.1007/s00330-011-2366-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  16 in total

1.  The many facets of intestinal peristalsis.

Authors:  J D Huizinga; C M McKay; E J White
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-06       Impact factor: 4.052

2.  A comparison of the value of hyoscine butylbromide and glucagon on aorto iliac intravenous digital subtraction.

Authors:  C A Rowland-Hill; E J Loveday; M L Thomas
Journal:  Vasa       Date:  1989       Impact factor: 1.961

3.  Small bowel motility assessment with magnetic resonance imaging.

Authors:  Johannes M Froehlich; Michael A Patak; Constantin von Weymarn; Christoph F Juli; Christoph L Zollikofer; Klaus-Ulrich Wentz
Journal:  J Magn Reson Imaging       Date:  2005-04       Impact factor: 4.813

Review 4.  The patterns of small bowel motility: physiology and implications in organic disease and functional disorders.

Authors:  E Husebye
Journal:  Neurogastroenterol Motil       Date:  1999-06       Impact factor: 3.598

5.  The value of hyoscine butylbromide in abdominal MR imaging with and without oral magnetic particles.

Authors:  M Laniado; E Grönewäller; A F Kopp; S F Kaminsky; B Hamm; T F Jacobsen; C D Claussen
Journal:  Abdom Imaging       Date:  1997 Jul-Aug

6.  Assessment of small bowel motility function with cine-MRI using balanced steady-state free precession sequence.

Authors:  Makoto Wakamiya; Akira Furukawa; Shuzo Kanasaki; Kiyoshi Murata
Journal:  J Magn Reson Imaging       Date:  2011-05       Impact factor: 4.813

Review 7.  International Union of Pharmacology. XXXV. The glucagon receptor family.

Authors:  Kelly E Mayo; Laurence J Miller; Dominique Bataille; Stéphane Dalle; Burkhard Göke; Bernard Thorens; Daniel J Drucker
Journal:  Pharmacol Rev       Date:  2003-03       Impact factor: 25.468

8.  Reduction of bowel motion artifact during digital subtraction angiography: a comparison of hyoscine butylbromide and glucagon.

Authors:  R I Kozak; J D Bennett; T C Brown; T Y Lee
Journal:  Can Assoc Radiol J       Date:  1994-06       Impact factor: 2.248

9.  The value of hyoscine butylbromide in pelvic MRI.

Authors:  W Johnson; M B Taylor; B M Carrington; S C Bonington; R Swindell
Journal:  Clin Radiol       Date:  2007-08-20       Impact factor: 2.350

Review 10.  Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators.

Authors:  Philip E Dubé; Patricia L Brubaker
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-07-24       Impact factor: 4.310

View more
  18 in total

Review 1.  MRI for the diagnosis and staging of deeply infiltrating endometriosis: a national survey of BSGE accredited endometriosis centres and review of the literature.

Authors:  Marianne Wild; Shikha Pandhi; John Rendle; Ian Swift; Emmanuel Ofuasia
Journal:  Br J Radiol       Date:  2020-07-30       Impact factor: 3.039

2.  Elective surgery outcomes in inflammatory bowel disease: interpretation at magnetic resonance enterography.

Authors:  Giuseppe Cicero; Giorgio Ascenti; Alfredo Blandino; Renato Trimarchi; Christian Booz; Thomas J Vogl; Tommaso D'Angelo; Silvio Mazziotti
Journal:  Jpn J Radiol       Date:  2021-02-24       Impact factor: 2.374

3.  Use of intravenous hyoscine butylbromide (Buscopan) during gastrointestinal endoscopy.

Authors:  Thomas Lee; John Anderson; Siwan Thomas-Gibson; Colin Rees
Journal:  Frontline Gastroenterol       Date:  2017-08-18

Review 4.  Do antispasmodics or rectal enemas improve image quality on multiparametric prostate MRI? An 'Evidence-Based Practice' review of the literature.

Authors:  Daniel L Brennan; Smaro Lazarakis; Allan Lee; Teng H Tan; Kwang Y Chin; Sheng F Oon
Journal:  Abdom Radiol (NY)       Date:  2021-01-19

5.  Value of bowel preparation techniques for prostate MRI: a preliminary study.

Authors:  Cynthia Schmidt; Andreas M Hötker; Urs J Muehlematter; Irene A Burger; Olivio F Donati; Borna K Barth
Journal:  Abdom Radiol (NY)       Date:  2021-03-26

6.  Indications and selection of MR enterography vs. MR enteroclysis with emphasis on patients who need small bowel MRI and general anaesthesia: results of a survey.

Authors:  Michael R Torkzad; Gabriele Masselli; Steve Halligan; Aytek Oto; Henning Neubauer; Stuart Taylor; Arun Gupta; Jens Brøndum Frøkjær; Ian C Lawrance; Christopher J Welman; Anne Negård; Olle Ekberg; Michael Patak; Thomas Lauenstein
Journal:  Insights Imaging       Date:  2015-04-09

7.  Hyoscine butylbromide for colorectal polyp detection: prospective, randomized, placebo-controlled trial.

Authors:  Carlos Eduardo Oliveira Dos Santos; Hamilton Moreira; Julio Carlos Pereira-Lima; Carmen Australia Paredes Marcondes Ribas; Fernanda de Quadros Onófrio; Alexandre Eduardo Augusti Czecko; Rafael Koerich Ramos; Caroline Aragão de Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2017-07       Impact factor: 2.365

8.  The challenge of segmental small bowel motility quantitation using MR enterography.

Authors:  A Menys; A Plumb; D Atkinson; S A Taylor
Journal:  Br J Radiol       Date:  2014-06-12       Impact factor: 3.039

9.  The first joint ESGAR/ ESPR consensus statement on the technical performance of cross-sectional small bowel and colonic imaging.

Authors:  S A Taylor; F Avni; C G Cronin; C Hoeffel; S H Kim; A Laghi; M Napolitano; P Petit; J Rimola; D J Tolan; M R Torkzad; M Zappa; G Bhatnagar; C A J Puylaert; J Stoker
Journal:  Eur Radiol       Date:  2016-10-18       Impact factor: 5.315

Review 10.  Magnetic resonance imaging biomarkers of gastrointestinal motor function and fluid distribution.

Authors:  Asseel Khalaf; Caroline L Hoad; Robin C Spiller; Penny A Gowland; Gordon W Moran; Luca Marciani
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.